Key points Glucagon-like peptide 1 receptor (GLP1R) agonists and dipeptidyl peptidase 4 (DPP4) inhibitors reduce the onset and progression of albuminuria in patients with type 2 diabetes mellitus (T2DM)
, NNMT , 2 , ,
Youll be able to find clinical trials at all different phases, including: New, not yet recruiting Active, recruiting Active, not recruiting Completed One thing to keep in mind: Clinicaltrials.gov is maintained by The National Library of Medicine (NLM), but the government doesnt review or approve the safety of the clinical trials
The effect of 4-week aerobic exercise and dietary control on serum IGF-1 and IGF-1 binding protein-3 levels in obese female adolescents
In addition, when DPP4i is combined with insulin secretin or insulin itself, DPP4i provides a complementary effect due to its inhibition of glucagon secretion and reduction in hepatic glucose production, which also means that a beneficial effect on glucose control can be achieved even with reduced cell function [94]
2013 [cited 2020 Aug 24];81:591606